Your browser doesn't support javascript.
loading
Evaluation of venous thromboembolism risk factors reveals subtype heterogenicity in children with central venous catheters: a multicenter study from the Children's Hospital Acquired Thrombosis consortium.
Jaffray, Julie; Mosha, Maua; Branchford, Brian; Goldenberg, Neil A; Silvey, Michael; Croteau, Stacy E; Fargo, John H; Cooper, James D; Bakeer, Nihal; Stillings, Amy; Krava, Emily; Young, Guy; Amankwah, Ernest K.
Affiliation
  • Jaffray J; Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA; Division of Hematology/Oncology, Rady Children's Hospital, San Diego, California, USA. Electronic address: jjaffray@rchsd.org.
  • Mosha M; Data Coordinating Center, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida, USA.
  • Branchford B; Versiti Medical Sciences Institute, Milwaukee, Wisconsin, USA; Division of Hematology/Oncology, Children's Wisconsin Hospital, Milwaukee, Wisconsin, USA.
  • Goldenberg NA; Data Coordinating Center, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida, USA; Departments of Pediatrics and Medicine, Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Silvey M; Division of Hematology/Oncology, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Croteau SE; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
  • Fargo JH; Division of Hematology/Oncology, Akron Children's Hospital, Akron, Ohio, USA.
  • Cooper JD; Division of Hematology/Oncology, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Bakeer N; Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA.
  • Stillings A; Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Krava E; Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Young G; Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA; Division of Hematology/Oncology, Rady Children's Hospital, San Diego, California, USA.
  • Amankwah EK; Data Coordinating Center, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida, USA; Departments of Oncology and Pediatrics, Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Thromb Haemost ; 21(9): 2441-2450, 2023 09.
Article de En | MEDLINE | ID: mdl-37100395
ABSTRACT

BACKGROUND:

Acutely ill and medically complex children frequently rely on central venous catheters (CVCs) to provide life-sustaining treatment. Unfortunately, catheter-related thrombosis (CRT) is a serious and common complication. Little is known why some with a CVC develop CRT and others develop venous thromboembolism unrelated to the CVC (non-CRT).

OBJECTIVES:

The aim of this study was to identify factors associated with CRT in children with hospital-acquired venous thromboembolism (HA-VTE).

METHODS:

This case-case study included participants in the Children's Hospital Acquired Thrombosis Registry with HA-VTE and CVC aged 0 to 21 years from 8 US children's hospitals. Participants were excluded if they developed HA-VTE prior to CVC insertion or if the CVC insertion date was unknown. Logistic regression models were used to assess associations between clinical factors and CRT status.

RESULTS:

There were 1144 participants with HA-VTE who had a CVC. CRT developed in 833 participants, and 311 developed non-CRT. Multivariable analysis showed increased odds of CRT (compared with non-CRT) in participants with peripherally inserted central catheters (odds ratio [OR], 3.80; 95% CI, 2.04-7.10; p < .001), CVCs inserted in the femoral vein (OR, 4.45; 95% CI, 1.70-11.65; p = .002), multiple CVCs (OR, 1.42; 95% CI, 1.18-1.71; p < .001), and CVC malfunction (OR, 3.30; 95% CI, 1.80-6.03; p < .001).

CONCLUSION:

The findings of this study provide new insights on risk factor differences between CRT and non-CRT. Prevention efforts should be directed at modifying the type of CVC, insertion location, and/or number of CVCs placed, if possible, to decrease the incidence of CRT.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thrombose / Cathétérisme veineux central / Thromboembolisme veineux / Voies veineuses centrales Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Humans Langue: En Journal: J Thromb Haemost Sujet du journal: HEMATOLOGIA Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thrombose / Cathétérisme veineux central / Thromboembolisme veineux / Voies veineuses centrales Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Humans Langue: En Journal: J Thromb Haemost Sujet du journal: HEMATOLOGIA Année: 2023 Type de document: Article